Global OTC Anti-Infective Products Market Growth 2023-2029

Global OTC Anti-Infective Products Market Growth 2023-2029

Anti-infectives are medicines that work to prevent or treat infections.
Anti-infective drugs used for the purpose of killing or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites.
LPI (LP Information)' newest research report, the “OTC Anti-Infective Products Industry Forecast” looks at past sales and reviews total world OTC Anti-Infective Products sales in 2022, providing a comprehensive analysis by region and market sector of projected OTC Anti-Infective Products sales for 2023 through 2029. With OTC Anti-Infective Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world OTC Anti-Infective Products industry.
This Insight Report provides a comprehensive analysis of the global OTC Anti-Infective Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on OTC Anti-Infective Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global OTC Anti-Infective Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for OTC Anti-Infective Products and breaks down the forecast by type, by sales channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global OTC Anti-Infective Products.
The global OTC Anti-Infective Products market size is projected to grow from US$ 13030 million in 2022 to US$ 16610 million in 2029; it is expected to grow at a CAGR of 16610 from 2023 to 2029.
Global core OTC anti-infective products manufacturers include Teva, MYLAN and NOVARTIS etc. The Top 3 companies hold a share above 10%. Asia-Pacific is the largest market, with a share about 38%, followed by North America and Europe with the share about 30% and 20%.
This report presents a comprehensive overview, market shares, and growth opportunities of OTC Anti-Infective Products market by product type, sales channel, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Antifungal
Antibacterial
Antiviral
Antiseptics
Others
Segmentation by sales channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer
GSK
Teva
Johnson & Johnson
NOVARTIS
MYLAN
Sun Pharma
CR SANJIU
Cipla
Lingrui

Key Questions Addressed in this Report
What is the 10-year outlook for the global OTC Anti-Infective Products market?
What factors are driving OTC Anti-Infective Products market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do OTC Anti-Infective Products market opportunities vary by end market size?
How does OTC Anti-Infective Products break out type, sales channel?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.